Intraoperative Treatment of Duct of Luschka during Laparoscopic Cholecystectomy: A Case Report and Revision of Literature

Case Reports in Surgery ◽

10.1155/2018/9813489 ◽

2018 ◽

Vol 2018 ◽

pp. 1-3

Author(s):

Luigi Masoni ◽

Leandro Landi ◽

Riccardo Maglio

Keyword(s):

Case Report ◽

Bile Leak ◽

Bile Leakage ◽

Medical Systems ◽

Invasive Treatment ◽

Endoscopic Clip ◽

First Case ◽

Duct Of Luschka ◽

Clinically Significant

Background. Bile leakage still remains a serious complication during cholecystectomies. In limited cases, this complication may occur from injury of the so-called ducts of Luschka. These rare ducts are usually discovered intraoperatively, and their presence poses the risk of bile injury and clinically significant bile leak. Presentation Case. We present a unique case of a 59-year-old male patient with acute cholecystitis. After removal of the gallbladder, thorough inspection of the hepatic bed was made and a little bile leak was identified from a duct of Luschka 1 cm away from the gallbladder hilum. We report on the use of endoscopic QuickClip Pro® clips (Olympus Medical Systems Corp., Tokyo, Japan) to avoid further more invasive treatment. Discussion. Endoscopic retrograde cholangiopancreatography with sphincterotomy played a crucial role for diagnosis and treatment of bile leaks with success rate near 94%. Many authors have argued the role of relaparoscopy, Diagnosis may be intraoperatively but this option does not seem to occur very often; in fact, there is a lack of data in literature. Conclusion. This is the first case report of bile leak from duct of Luschka treated during the cholecystectomies with endoscopic clip.

Download Full-text

First case report of bile leak from the duct of Luschka in a patient with mini-gastric bypass: The challenge of management

Annals of Medicine and Surgery ◽

10.1016/j.amsu.2018.09.018 ◽

2018 ◽

Vol 35 ◽

pp. 29-32 ◽

Cited By ~ 2

Author(s):

Houssam Khodor Abtar ◽

Tarek Mostafa Mhana ◽

Riad Zbibo ◽

Mostapha Mneimneh ◽

Antoine el Asmar

Keyword(s):

Gastric Bypass ◽

Case Report ◽

Bile Leak ◽

Mini Gastric Bypass ◽

First Case ◽

Duct Of Luschka

Download Full-text

Role of Immunotherapy in Pulmonary Angiosarcoma: A Case Report

Case Reports in Oncology ◽

10.1159/000516402 ◽

2021 ◽

pp. 797-801

Author(s):

Quang Tien Nguyen ◽

Anh Tuan Pham ◽

Thuy Thi Nguyen ◽

Tam Thi Thanh Nguyen ◽

Ky Van Le

Keyword(s):

Case Report ◽

Poor Prognosis ◽

Checkpoint Inhibitor ◽

Therapeutic Strategies ◽

Clinical Entity ◽

Rare Clinical Entity ◽

Excellent Response ◽

First Case

Pulmonary angiosarcoma is a rare clinical entity with a poor prognosis and no established therapeutic strategies. We present the first case to our knowledge of metastatic pulmonary angiosarcoma, treated with checkpoint inhibitor immunotherapy, and have an excellent response. Until now, patient has been treated with immunotherapy for 1 year, and his disease is stable and well-tolerated.

Download Full-text

Medullary infarction causing coexistent SUNCT and trigeminal neuralgia

Cephalalgia ◽

10.1177/0333102416652093 ◽

2016 ◽

Vol 37 (5) ◽

pp. 486-490 ◽

Cited By ~ 8

Author(s):

Giorgio Lambru ◽

Michele Trimboli ◽

S Veronica Tan ◽

Adnan Al-Kaisy

Keyword(s):

Case Report ◽

Trigeminal Neuralgia ◽

Trigeminal Autonomic Cephalalgias ◽

Conjunctival Injection ◽

Neurovascular Conflict ◽

First Case ◽

Clinical Variants ◽

Broad Variety ◽

Medullary Infarction

Background Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or with autonomic symptoms (SUNA) are grouped together within the trigeminal autonomic cephalalgias (TACs). However, the SUNCT and SUNA phenotype and management overlap with those of trigeminal neuralgia (TN). Additionally, a broad variety of cerebral pathologies are reportedly able to trigger either TN- or SUNCT-like pain, and emerging structural neuroimaging findings suggest the possible role of neurovascular conflict with the trigeminal nerve in SUNCT, further supporting aetiological and pathophysiological overlaps among SUNCT, SUNA and TN. Case report We present the first case of coexisting chronic SUNCT- and TN-like phenotypes caused by haemorrhagic infarct of the dorsolateral medulla. Discussion In light of our case, a perturbation of the dorsolateral medullary circuits may constitute an important pathophysiological component, supporting a unifying nosological hypothesis that considers SUNCT, SUNA and TN clinical variants of the same disorder.

Download Full-text

Sarcoidosis Developing During Secukinumab Therapy: Case Report

SKIN The Journal of Cutaneous Medicine ◽

10.25251/10.25251/skin.1.2.7 ◽

2017 ◽

Vol 1 (2) ◽

pp. 95

Author(s):

Timothy Nyckowski ◽

Roger Ceilley ◽

Joshua Wilson

Keyword(s):

Case Report ◽

Psoriatic Arthritis ◽

Side Effect ◽

Pulmonary Involvement ◽

Unknown Etiology ◽

Systemic Involvement ◽

First Case ◽

Relationship Of ◽

The Relationship

Introduction: Sarcoidosis is a systemic granulomatous inflammatory disease with an unknown etiology and complex pathogenesis. Existing literature supports the relationship of new-onset sarcoidosis with the use of a several biologic agents. Since the skin is the second most commonly involved organ in sarcoidosis and often precedes systemic involvement, dermatologists must be able to recognize its non-specific clinical presentation.Case Report: We present a 45 year old female with psoriatic arthritis who developed biopsy proven cutaneous sarcoidal granulomas with pulmonary involvement shortly after initiating secukinumab for treatment of psoriatic arthritis. Despite discontinuation of secukinumab, the sarcoidosis has persisted.Discussion: This is the first case report of secukinumab, or any IL-17 inhibitor related sarcoidosis that we are aware of in the literature. Dermatologists should be aware of this as a possible side effect of secukinumab use. As the research on the role of IL-17 in the pathogenesis of sarcoidosis continues to develop, the implications of this side effect of IL-17 inhibition may have important future implications.

Download Full-text

Acetabular liner dissociation: A case report and review of the literature

SICOT-J ◽

10.1051/sicotj/2019025 ◽

2019 ◽

Vol 5 ◽

pp. 31

Author(s):

Asif A.H. Parkar ◽

Mohamed Sukeik ◽

Ahmed El-Bakoury ◽

James Powell

Keyword(s):

Case Report ◽

Total Hip Arthroplasty ◽

Polyethylene Liner ◽

Review Of The Literature ◽

Acetabular Liner ◽

First Case ◽

Ceramic Liner ◽

Acetabular Shell ◽

Acetabular Components

Dissociation of the polyethylene liner from the acetabular shell is a rare but catastrophic complication of total hip arthroplasty (THA). There have been reports of polyethylene liner dissociation (PLD) as well as ceramic liner dissociation (CLD) in the literature. Amongst the commonly used implants, liner dissociation has been reported with the Pinnacle (DePuy), Harris–Galante (Zimmer) and Trident (Stryker) acetabular components. To the best of our knowledge, this is the first case report of PLD in an R3 (Smith & Nephew) acetabular component. This case report highlights the implant choice for treatment of the liner dissociation and the role of constrained implants in such cases.

Download Full-text

Ocular manifestation in progeria: A case report

Nepalese Journal of Ophthalmology ◽

10.3126/nepjoph.v12i1.25454 ◽

2020 ◽

Vol 12 (1) ◽

pp. 133-138

Author(s):

Rinkal Suwal ◽

Pranita Dhakal ◽

Purushottam Joshi

Keyword(s):

Case Report ◽

Bright Light ◽

Ocular Manifestations ◽

First Case ◽

Musculoskeletal Abnormalities ◽

One Year ◽

Progeria Syndrome ◽

Hutchinson Gilford Progeria Syndrome ◽

Delayed Growth

Introduction: Progeria also known as Hutchinson Gilford Progeria Syndrome (HGPS) (MIM176670) is a very uncommon fatal genetic untimely aging syndrome. It is characterized by retarded physical development, accelerated degeneration of the skin, cardiovascular and musculoskeletal abnormalities. Other features include prominent eyes, thin nose, small chin and thin lips. Eyebrow hair loss, madarosis and lagopththalmos are the common ocular manifestations. Case: We report a case of five year old boy with complaints of discomfort in bright light and a whitish appearance in his right eye for two months. He was accompanied by the parents. They complained of loss of eyelashes and eyebrows. In the developmental history he was normal at birth till the age of one year then they noticed gradual hair fall, delayed growth, wrinkling of skin, increase in size of head and thinning of limbs. Conclusion: This is the first case report from Nepal with the ocular presentation of progeria indicating the role of ocular senescence in patients with Hutchinson Progeria Gilford Syndrome.

Download Full-text

Interstitial Lung Disease in a Patient Treated with Denosumab

European Journal of Case Reports in Internal Medicine ◽

10.12890/2019_001131 ◽

2019 ◽

Author(s):

Ana Campo Ruiz ◽

Miguel F Carrascosa ◽

Sergio Tapia Concha ◽

Anibal Hernández Gil ◽

Juan García Rivero

Keyword(s):

Case Report ◽

Interstitial Lung Disease ◽

Adverse Effects ◽

Lung Disease ◽

English Literature ◽

Osteonecrosis Of The Jaw ◽

Femur Fractures ◽

First Case ◽

Atypical Femur Fractures ◽

Clinically Significant

Denosumab is an antiresorptive agent widely used for treating osteoporosis. Atypical femur fractures, osteonecrosis of the jaw and hypocalcaemia are well-known possible adverse effects of this drug. We present, to our knowledge, the first case report in the English literature of clinically significant interstitial lung disease likely related to denosumab.

Download Full-text

Severe Toxicity with a Generic Formulation of Zoledronic Acid: A Case Report

Clinical Medicine Insights Case Reports ◽

10.4137/ccrep.s8825 ◽

2012 ◽

Vol 5 ◽

pp. CCRep.S8825 ◽

Cited By ~ 1

Author(s):

Benito Sanchez

Keyword(s):

Breast Cancer ◽

Case Report ◽

Zoledronic Acid ◽

Bone Pain ◽

Severe Toxicity ◽

Brand Name ◽

First Case ◽

Significant Difference ◽

Additional Costs ◽

Clinically Significant

Intravenous zoledronic acid (ZOL) is an integral component for the management of patients with bone metastases, but can be associated with transient flu-like symptoms, which generally occur only with the first infusion and are typically manageable with non-prescription analgesics. A 50-year-old woman with a bone metastasis secondary to breast cancer received radiation therapy, brand-name ZOL (Zometa®), and letrozole. During the first 3 cycles of Zometa (4 mg every 3–4 weeks), no acute adverse events were reported. For the next 2 cycles she was switched to generic ZOL and experienced severe toxicity (nausea, vomiting, extreme weakness, and incapacitating bone pain) that required hospitalization. Toxicity differences between generic ZOL and Zometa led the patient to pay additional costs for Zometa, and subsequent Zometa infusions were without incident. This is the first case report documenting a clinically significant difference between the safety profiles of a generic formulation of ZOL and brand-name Zometa.

Download Full-text